Profits lag behind sales growth at Disetronic
This article was originally published in Clinica
Executive Summary
The net income of the Swiss drug delivery company, Disetronic went up by 10% to reach SwFr22 million ($15 million), in the year ended March 31, while total sales increased by 29% to SwFr132 million. The company, of Burgdorf, said that the disproportionately small growth in net income, compared with sales growth, was due to a more conservative investment policy and the currency movements.